Don’t let the high cost of brand ultra-long-acting basal insulin disrupt your diabetes care. We help eligible patients access Tresiba (insulin degludec) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Tresiba PAP for diabetes patients.
Eligibility verification.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$480/pack | Save substantially |
| CVS Pharmacy | ~$500/pack | Save substantially |
| Walmart | ~$370/pack | Save substantially |
| Costco | ~$360/pack | Save substantially |
Semglee glargine (alt) | ~$150/pack | Different drug, cheaper |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
PAP at no cost. Generic insulin glargine (Semglee) alternative basal insulin much cheaper. Medicare $35 cap.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Tresiba:
Still $350–$500/pack per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Tresiba assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Tresiba is insulin degludec — multi-hexamer self-association at injection site provides ultra-stable absorption with >42-hour half-life. Flattest basal insulin profile available.
How Tresiba Works:
Insulin degludec forms multi-hexamers in subcutaneous depot — gradually dissociates and absorbs over many hours.
Ultra-long half-life provides 24+ hour basal coverage with dosing-time flexibility (within 8–40 hours acceptable). Flatter than glargine, less hypoglycemia in some trials (DEVOTE).
Form and use:
Tresiba SC injection once daily — flexible timing. FlexTouch prefilled pen, U-100 or U-200 concentrations.
Generic availability:
No biosimilar Tresiba currently. Insulin glargine U-100 (Lantus brand, Semglee interchangeable biosimilar, Basaglar follow-on, Rezvoglar) — different basal insulin, much cheaper, similar clinical effect for most patients.
Warnings:
Hypoglycemia, hypokalemia, lipodystrophy, hypersensitivity.
Tresiba $350–$500/pack. Semglee (glargine) ~$150. Medicare $35 cap.
Tresiba has flattest, longest profile (>42 hours). Modest clinical advantage (less hypoglycemia in DEVOTE trial). Glargine generics/biosimilars dramatically cheaper. Choice often by insurance coverage and individual response.
Tresiba can be dosed any time of day with intervals 8–40 hours acceptable — more flexibility than glargine.
Yes since 2023.
Semglee glargine (different drug, much cheaper). Medicare cap. Manufacturer copay.
If facing Tresiba cost, Semglee glargine biosimilar or Medicare $35 cap. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.